why choose us

First received: October 21, 2022

Clinical Trial: RE-BLEED: A Digital Platform for Identifying Bleeding Patients - a Feasibility Study

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Hemorrhage

Study Type: OBSERVATIONAL


Official Title: RE-BLEED: A Digital Platform for Identifying Bleeding Patients - a Feasibility Study

Brief Summary: The RE-BLEED feasibility study aims to develop and test a real-time digital platform, whereby bleeding patients in-hospital can be identified and approached for their consent to participate in future research studies.

Read more